Journal Basic Info
- Impact Factor: 1.995**
- H-Index: 8
- ISSN: 2474-1647
- DOI: 10.25107/2474-1647
Major Scope
- Obstetrics Surgery
- Plastic Surgery
- Urology
- Oral and Maxillofacial Surgery
- Bariatric Surgery
- Gynecological Surgery
- General Surgery
- Surgical Oncology
Abstract
Citation: Clin Surg. 2019;4(1):2663.Research Article | Open Access
The Evaluation of Laparoscopic Radical Pancreaticoduodenectomy for Pancreatic Head Cancer with Programmed Process
Li Guolin, Zheng Shangyou, Wei lusheng, Lin Qing, Zhou Quanbo and Chen Rufu
Department of Biliopancreatic Surgery, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, P.R. China
Department of General Surgery, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, P.R. China
These authors contributed equally to this work
PDF Full Text DOI: 10.25107/2474-1647.2663
Abstract
Objective: To evaluate the safety and availability of laparoscopic radical pancreaticoduodenectomy following programmed process. Methods: 38 cases with pathologically confirmed pancreatic ductal adenocarcinoma who had undergone Laparoscopic Radical Pancreaticoduodenectomy (LRPD) in Sun Yet-Sen Memorial Hospital from January 2016 to May 2018 were retrospectively analyzed. Several indicators of perioperative period were analyzed. Results: 38 cases were successfully performed under total laparoscopy. The average operation time was (281.0 ± 76.0) min, blood loss was (138.2 ± 144.0) ml, acquired lymph node was (15.1 ± 9.0), the postoperative exhaust time was (50.4 ± 12.1) h, and the average postoperative hospital stay was (11.3 ± 3.3) days. No grade C pancreatic fistula was found in the group. Conclusion: Followed accurate preoperative evaluation, procedural procedure of laparoscopic radical pancreaticoduodenectomy is safe and feasible.
Keywords
Laparoscopic surgery; Pancreatic head cancer; Pancreaticoduodenectomy; Programmed process
Cite the article
Guolin L, Shangyou Z, lusheng W, Qing L, Quanbo Z, Rufu C. The Evaluation of Laparoscopic Radical Pancreaticoduodenectomy for Pancreatic Head Cancer with Programmed Process. Clin Surg. 2019; 4: 2663.